Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Thigpen T.   Blessing J.A.   Yordan E.   Valea F.   Vaccarello L.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 120-122

Academic Press

Access to resources Recommend Favorite

Trimetrexate in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus: A Phase II Study of the Gynecologic Oncology Group

By Smith H.O.   Blessing J.A.   Vaccarello L.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 140-144

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Paclitaxel in Patients with Advanced or Recurrent Adenocarcinoma of the Endometrium: A Gynecologic Oncology Group Study

By Ball H.G.   Blessing J.A.   Lentz S.S.   Mutch D.G.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 278-281

Academic Press

Access to resources Recommend Favorite

Phase II Trial of Hydroxyurea, Dacarbazine (DTIC), and Etoposide (VP-16) in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group Study

By Currie J.L.   Blessing J.A.   McGehee R.   Soper J.T.   Berman M.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 94-96

Academic Press

Access to resources Recommend Favorite

Paclitaxel in the Treatment of Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Curtin J.P.   Blessing J.A.   Soper J.T.   DeGeest K.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 268-270

Elsevier

Access to resources Recommend Favorite